GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

55 hedge funds and large institutions have $15.2M invested in Galectin Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 20 closing their positions.

Holders
55
Holders Change
-15
Holders Change %
-21.43%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
15
Reduced
11
Closed
20
Calls
$759K
Puts
$348K
Net Calls
+$411K
Net Calls Change
-$1.2M

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$446K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$351K
3
Millennium Management
3
Millennium Management
New York
$840K
4
SF
4
Synovus Financial
Georgia
$99K
5
Morgan Stanley
5
Morgan Stanley
New York
$194K

Top Sellers

1
E
1
Ergoteles
New York
$0
2
HF
2
HRT Financial
New York
$0
3
Capstone Investment Advisors
3
Capstone Investment Advisors
New York
$0
4
PPA
4
Parametric Portfolio Associates
Washington
$0
5
CF
5
Centaurus Financial
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Jane Street
76
Jane Street
New York
– – – –
JPMorgan Chase & Co
77
JPMorgan Chase & Co
New York
$0 43 – –
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
Fidelity Investments
79
Fidelity Investments
Massachusetts
$0 45 – –
1 2 3
4